Impressive response to four cemiplimab cycles of a sonidegib‐resistant giant basosquamous carcinoma of the midface
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17993
Abstract: tion. If TB is diagnosed during the use of a biological, it must be discontinued immediately, and anti-TB therapy should be initiated. It is safe to restart the biological after successful completion of treatment. However,… read more here.
Keywords: cycles sonidegib; sonidegib resistant; cemiplimab cycles; four cemiplimab ... See more keywords